STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 83 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 6.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,370,000 | -70.0% | 1,316,106 | -34.2% | 0.07% | -63.2% |
| Q4 2019 | $21,260,000 | +25.7% | 2,000,000 | +23.1% | 0.18% | +21.7% |
| Q3 2019 | $16,916,000 | -26.4% | 1,625,000 | +8.3% | 0.15% | -24.8% |
| Q2 2019 | $22,980,000 | -5.9% | 1,500,000 | -21.1% | 0.20% | -11.0% |
| Q1 2019 | $24,415,000 | +11.6% | 1,900,000 | -17.5% | 0.23% | -3.0% |
| Q4 2018 | $21,875,000 | -35.8% | 2,302,666 | +12.1% | 0.23% | -19.3% |
| Q3 2018 | $34,097,000 | +11.1% | 2,054,050 | +7.4% | 0.29% | +56.8% |
| Q2 2018 | $30,697,000 | +438.1% | 1,912,605 | +412.4% | 0.18% | +219.0% |
| Q1 2018 | $5,705,000 | – | 373,285 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |